
New dilemma looms for India's private hospitals: More beds, but few can lie in them
private hospitals
.
Capacity expansion lined up by top players and recent record investments and blockbuster deals in the sector may result in a transition from capacity crunch to overcapacity in a short span in major urban areas, even as the number of beds continue to be an issue in small cities and towns.
Explore courses from Top Institutes in
Select a Course Category
Degree
Cybersecurity
Leadership
Public Policy
Finance
healthcare
MBA
Healthcare
Data Science
Digital Marketing
CXO
Product Management
Data Analytics
Operations Management
MCA
others
Technology
Design Thinking
Management
Data Science
Others
Artificial Intelligence
PGDM
Project Management
Skills you'll gain:
Data-Driven Decision-Making
Strategic Leadership and Transformation
Global Business Acumen
Comprehensive Business Expertise
Duration:
2 Years
University of Western Australia
UWA Global MBA
Starts on
Jun 28, 2024
Get Details
According to estimates by leading healthcare consultants and industry experts, more than 50,000 beds are likely to be added in the organised hospitals sector in the next three-four years, with chains like Apollo Healthcare, Aster DM Healthcare, Fortis Healthcare and Max Healthcare leading the way.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Villas Prices In Dubai Might Be More Affordable Than You Think
Villas In Dubai | Search Ads
Get Quote
Undo
But affordability problems persist, though the situation is improving. While the addition of more beds can help close the gap in India's poor bed to patient ratio—1.4 beds to 1,000 people—data shows that 75% of the healthcare infrastructure in metro cities is catering to a third of their population.
The World Health Organization(WHO) recommends about three beds per 1,000 people; Indian public health standards recommend a minimum of one bed, desirably two.
Live Events
In India's metros, there are 2.5-3.5 beds per 1,000 people, but when it comes to quality, the bed density varies from as low as 0.4 to 1.0, estimates Kaivaan Movdawalla, partner and
Healthcare Sector
leader at EY-Parthenon India.
The numbers point to the need for more affordable healthcare delivery from private hospitals, something that can enable an increase in capacity utilisation and drive long-term profitability.
The good news is that demand for private healthcare has been growing. 'Post Covid, we are seeing a much greater momentum towards organised quality private healthcare,' said Movdawalla.
'The key supply drivers are the high disease burden, expanding middle class and unlocking of demand for the bottom of the pyramid through social insurance,' he added.
'A discernible shift of demand towards organised quality hospital segments is evident now. We see a demand-supply gap for quality beds to the tune of 25-40%,' he added.
But without affordability, filling them might remain a problem.
MUTED PROFITABILITY
Analysts also warn that the flow of investment and the wave of capacity expansion lined up by leading chains in the next 3-4 years could weigh on profitability and margins of the leading hospital chains.
Global financial services firm Macquarie in a recent report maintained a cautious stance on
Indian hospitals
due to an upcoming capacity deluge with organic bed addition in the next four years slated to be four times that of what was added in the last five years. The report stated that profitability improvement in existing hospitals remained muted and even small bed capacity expansion was driving profitability compression. 'We expect private hospitals to add 40% capacity organically in the next 3 years… Eight large-listed hospital chains are slated to add over 15,000 beds in the next 3-5 years versus addition of about 3,400 in the last five years,' the report said.
INVESTOR LINEUP
Challenges notwithstanding, the sector which has seen a flurry of investments in the last few years — especially post Covid — continues to remain a private equity favourite. Last week, Bengaluru-based Manipal Hospitals bought Pune-based Sahyadri Hospitals Group from Canada's Ontario Teachers' Pension Plan (OTPP) for around ?6,000 crore. Integration of Sahyadri with it will take Manipal's total capacity to about 12,000 beds.
Another Bengaluru-based hospital chain, Aster DM Healthcare, recently became the second largest healthcare chain in the country in terms of revenue after its merger with Blackstone-backed Quality Care. The company is eyeing the number one position, deputy managing director Alisha Moopen told ET.
In terms of bed capacity, Aster DM may be leading by a whisker with a total of 10,300 beds after the merger compared with the country's largest pan India hospital chain by revenue, Apollo Hospitals, which has a bed capacity of 10,187.
Aster DM plans to add 3,300 beds in the next couple of years, taking the total number of beds to 13,600. Apollo Hospitals plans to invest ?6,000 crore to add 4,300 beds. 'In the short-term, supply will outpace demand,' said an analyst with a leading brokerage. 'The primary growth driver for most multispecialty hospitals was not volume but it was ARPOB (average revenue per occupied bed — an industry metric), which was led by rate hikes of beds and procedures,' the person said.
Data from private equity firm Avendus shows that the hospital market in India is estimated to grow to $110 billion in the next 3-4 years from the current $76 billion, growing at a compounded annual rate of 10% driven by strong tailwinds from a rise in lifestyle diseases and increasing affordability. In 2019, or pre-Covid, the healthcare delivery market was $47 billion. Private hospitals and trusts currently constitute a 67% market share. Experts say that rising demand for quality healthcare, higher disposable income in small towns and rural areas and increasing insurance coverage will continue to drive more consolidation and M&As with a sharper focus on patient-centric models.
RISE OF SPECIALISED CARE
While large multispecialty hospitals are expanding through a combination of greenfield and brownfield expansion, single-specialty hospitals are increasingly gaining traction with rising demand from small towns.
'The share of single specialty will become larger in the next four years and the organised players will more than double,' said Anshul Gupta, managing director and head of healthcare investment banking at Avendus Capital.
The single-specialty format, where a hospital typically would have 40-50 beds, presents an opportunity for greater geographical depth compared to multispecialty hospitals where the average size is about 250-300 beds. Specialisations seeing demand include mother and child care, IVF and ophthalmology.
That is sparking consolidation. Large eye care chains like Dr Agarwal's Eye Hospital, Maxivision and others with PE backing have been acquiring anywhere between eight and 10 smaller players every year.
'Demand for quality care is going up in rural areas with rising disposable income and for quality care there will be takers. There are a lot of untapped cities where there is demand,' said Bhanu Prakash, partner and Healthcare Services Industry leader at Grant Thornton. 'Focus will be on optimising capacity utilisation and improving ARPOBs,' he said. This is where single-specialty models will play a crucial role, he said.
Total private equity investments in the single-specialty sector crossed $3.7 billion, accounting for over 35% of total hospital investments in the last 10 years. About 70% of these investments have gone to established specialties such as IVF, eyecare, mother & childcare, dialysis and oncology.
There is also a significant growth opportunity — especially for single specialty hospitals — in smaller cities such as Lucknow, Vizag, Jaipur, Kochi, Siliguri, Guwahati, Bhubaneswar, Patna, among others, with an increasing number of consumers wanting access to quality healthcare closer home.
The rising demand and lack of supply are prompting larger players also to expand in non-metros. Aster DM, for instance, will expand operations to cities such as Indore, Raipur, Aurangabad and Bhubaneshwar.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India.com
10 minutes ago
- India.com
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is….
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is…. Get Rs 2 lakh insurance for just a cost of two tea cups. Know about Pradhan Mantri Suraksha Bima Yojana here. By Joy Pillai Edited by Joy Pillai Advertisement Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is.... Pradhan Mantri Suraksha Bima Yojana: Many people have a habit of drinking tea and smoking cigarettes. This habit affects health and, in the long run, causes serious diseases. But what if we tell you that you can buy insurance worth Rs 2 lakh just by skipping two cups of tea or a cigarette? Today, we are telling you about an insurance scheme that provides financial security at a very low premium. No, it is not a fraud scheme, and there are no hidden charges either, because the scheme is run by the Government of India. The name of this scheme is Pradhan Mantri Suraksha Bima Yojana (PMSBY). Let's know more about the scheme. What Is Pradhan Mantri Suraksha Bima Yojana? Pradhan Mantri Suraksha Bima Yojana is basically an accident insurance scheme which offers accidental death and disability cover on account of an accident. The aim of the scheme is to provide financial strength to economically weaker families. The premium under PMSBY is only Rs. 20 per year. Under this scheme, you can also deposit a premium of Rs. 2 every month. Under this scheme, this amount is deducted from your Aadhaar linked bank account every year. Advertisement === Key Features Of PMSBY If the insured person becomes completely disabled in an accident, then he is eligible to get Rs 2 lakh. In case of a partial accident, Rs 1 lakh is given under the scheme. Advertisement === The insurance can be renewed every year. If the policyholder dies, then this money is given to the family. Who Can Avail The Benefit? People between the ages of 18 to 70 can avail themselves of the benefits of the scheme. Notably, this policy ends automatically on completion of the age of 70 years. Only Indian citizens are eligible for the security insurance scheme. The applicant must have an active bank account in any bank, which is linked to Aadhaar. If your bank account is closed then this policy will also end. The policy cover period is between 1st June to 31st May. What Is The Process Of Applying? To apply for this insurance program, apply at your bank. The bank will provide an application form which, once completed and submitted with the required documents, will initiate the process.


Time of India
22 minutes ago
- Time of India
Why are mentally ill soldiers being drafted in Ukraine?
Representative Image (AI-generated) M emory lapses, disorientation, confusion about numbers and colors: These are just some of the issues that Vasyl, a 28-year-old from central Ukraine, deals with on a daily basis. In fact, he's been receiving psychiatric care for a personality disorder since 2015. But none of that prevented the man — whose real name is being withheld for privacy reasons — being drafted into the Ukrainian military. According to his partner Olena, Vasyl never really acknowledges his problems and he may well have failed to do so during the physical examination he was given before joining the military. Vasyl was found to be fit for service and recently sent to southern Ukraine for basic training. Olena tried to explain all this to Vasyl's new commanding officer. After first being understanding, he dismissed the 2015 report from a psychiatric clinic that Olena brought him, saying that it was outdated. "But how can that not be grounds for discharge, if his condition is incurable?" Olena asks. DW has seen the report, which includes a list of Vasyl's problems. When he's stressed, the symptoms get worse, Olena notes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Seniors are going crazy for these comfy, stylish, easy-on shoes Ultra-Comfortable Shoes Undo That would make him a danger not only to himself but others. How can the mentally ill be drafted? There's a Ukrainian databank that military doctors refer to, in order to find out if potential recruits are sick in some way. It's called Helsi and on its website in English, it describes itself as "the most popular medical information system for healthcare institutions and medical portal for patients in Ukraine." But Vasyl's psychiatric diagnosis isn't in that system, says Ukrainian lawyer Yevhen Tsekhmister, because details about psychological illness can only be saved in there if the patient gives permission. If the diagnosis had been there, then according to the Ministry of Defense's Order No. 402, it would make Vasyl unfit for service. Order No. 402 determines what the military medical examination should look for and how to assess a soldier's fitness for duty. Tsekhmister explains that military doctors only trust official documentation because many men fake psychological disorders in order to avoid being drafted. "If legal counsel had been sought more quickly, and more up to date evidence had been provided, Vasyl would not have been drafted," the lawyer said. Thousands of complaints about draft: At the end of 2024, Ukrainian human rights activist Olha Reshetylova was appointed as a military ombudswoman by Ukraine's President Volodymyr Zelenskyy , so that soldiers and soldiers' families had a way to report violations of their rights. Reshetylova recommends that individuals take responsibility for updating their own medical history in the Helsi system and with the military, acknowledging that recruits' mental health can deteriorate during basic training. Senior officers don't want sick individuals serving in their units anyway, which is why they will often provide treatment if needed, she told DW. Since the beginning of this year, there have been more than 2,000 complaints about human rights violations committed during mobilization, Dmytro Lubinets, the Ukrainian parliament's commissioner for human rights, reports. In 2024, there were 3,500 such complaints in total. Although not all the complaints are justified, "we always react," he said. "There are cases where my local representatives will go to the draft board themselves to help citizens assert their rights," he told DW. "Thanks to our interventions, sick people have been discharged from the army." It's true that sick people have been drafted, Lubinets conceded, although here are no concrete numbers as to exactly how manty. "That can happen when staff ignore the medical documents or the condition of the person," Lubinets says. In general, he believes new recruits should be more carefully posted around the military. "Not every health problem automatically makes you unfit," he pointed out. "With back problems, you can't join the stormtroopers but you can work on a computer." Soldiers with 'no teeth, tuberculosis': A Ukrainian brigade commander told DW about his experiences with the recently drafted. He spoke on condition of anonymity. "I actually had the privilege of being able to choose my own men," he reported. "But some came with no teeth or they had tuberculosis — even at the training center!" Some of those men had already been offered to the brigades several times but nobody wanted them, not even to build trenches, he said. Kyrylo, whodidn't want to share his real name either, is another recent recruit who was drafted earlier this year. While at the draft board, he says he saw homeless people with swollen legs, drug addicts and alcoholics. The medical exam is often just a formality and in some places, it doesn't even happen, he says. It's not until you get to the training facility that a more thorough medical examination will be carried out. Another soldier, Oleksandr — who also didn't want to give his real name — says he even saw epileptics when he was drafted. This kind of recruitment actually led to a man with schizophrenia being assigned to a brigade of marines in 2024, after basic training, he recounts. Luckily the man's condition quickly became clear. "They didn't give him any weapons and sent him away after a few days," Oleksandr says. Tsekhmister doesn't think that sort of thing is all that uncommon. "A soldier, 1.75 meters tall, weighing 38 kilograms, with poor vision, a developmental disability and a malformed chest, can neither walk nor breathe in a bulletproof vest," the lawyer argues. "But he's been in the army since 2022. He's constantly transferred from one unit to another, or to hospitals, and he receives basic care." But since none of the various problems individually make him unfit for service, he can't be discharged on health grounds. The unit commanders can't give these kinds of soldiers "real" jobs, nor can they let them go. The situation is particularly bad among ground troops and logistics services because they've become a kind of "dumping ground" for unhealthy individuals, Tsekhmister explains. "They end up in brigades that are supposed to be building defense lines," he notes. "But they're useless there." A danger to themselves and others? Ukraine's Medical Forces Command, the service responsible for troops' medical support, insists things are being done the right way. "Military doctors' assessments are based on diagnoses made by specialists," Yuriy Podolyan, a colonel and the deputy commander of the Medical Forces, said in reply to DW's enquiries. "An assessment based on the combination of several illnesses is not provided for." Podolyan also said that the Ministry of Defense's Order No. 402 complies with local law and international standards. Military ombudswoman Reshetylova sees it differently and believes that the lack of possibility for that kind of assessment means something has gone wrong and needs review. The Ministry of Defense is apparently already working on that. As for Vasyl, his basic training is almost at an end and soon he will be assigned to a unit. Lawyer Tsekhmister is trying to organize a second psychiatric evaluation by military doctors. According to Vasyl's partner Olena, he has access to weapons. "If he ends up at the front, then he's a danger to the whole unit," Tsekhmister warns. "There's no way of predicting when his mental health will fail, or who might then be targeted."


Time of India
an hour ago
- Time of India
Ozempic and Wegovy may cut dementia risk by 45% and manage diabetes, study finds
Source: Reuters A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like Ozempic, Wegovy, and Mounjaro- may significantly reduce the risk of developing dementia. The analysis, conducted by Irish researchers and published in JAMA Neurology , involved data from over 164,000 participants and found that these medications reduced the risk of memory-robbing disorders by up to 45 per cent. These findings not only open new avenues for neurological protection but also position GLP-1 drugs as powerful tools in both metabolic and cognitive health management. Study links GLP-1 drugs like Ozempic and Mounjaro to lower dementia risk Researchers from the University of Galway reviewed 26 clinical trials involving 164,531 individuals—65% of whom were men, with an average age of 64. The participants were followed for an average of 31 months. The key discovery: patients taking GLP-1 agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) were 45% less likely to develop dementia compared to those on other glucose-lowering medications. Dr. Catriona Reddin, senior study author, said, 'Our findings suggest that GLP-1 receptor agonists, in particular, may have a protective effect on brain health.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo How GLP-1 agonists may protect against dementia Although the exact mechanism remains under investigation, researchers propose several pathways through which GLP-1 medications could shield the brain: Reduced neuroinflammation: These drugs may lower inflammation in the brain, which is known to damage neurons and trigger dementia symptoms. Decrease in amyloid and tau proteins: GLP-1 agonists could suppress the accumulation of toxic proteins linked to Alzheimer's disease. Improved blood vessel health: They may reduce blood pressure and enhance blood flow, preventing vascular dementia. Neurogenesis stimulation: Early research suggests these drugs may promote neural growth in the hippocampus, the brain region essential for memory. GLP-1 drugs may help prevent both diabetes and dementia The new study aligns with earlier research from the University of Florida, which followed 400,000 Americans and reported a 33% lower risk of dementia among GLP-1 users compared to other treatments. This growing body of evidence supports the role of semaglutide and tirzepatide not only in treating type 2 diabetes and obesity but potentially in preventing cognitive decline. Professor Martin O'Donnell, Dean at the University of Galway, emphasised, 'With both diabetes and dementia rising, these findings have major public health implications.' Dementia and diabetes: Twin epidemics in the US The study arrives amid alarming trends: Over 8 million Americans currently live with dementia, with 500,000 new cases diagnosed each year. Diabetes now affects 38 million people in the US; around 12% of the population. According to the Alzheimer's Association, Alzheimer's rates have climbed 25 consecutive years. The intersection of these two epidemics highlights the urgency of therapies that can address both conditions simultaneously. Study highlights need for more GLP-1 brain health data While the findings are promising, researchers caution that more work is needed to confirm the results. Notable limitations include: Lack of data on dementia subtypes like Lewy body and vascular dementia Differences in study design and follow-up durations Unclear long-term cognitive outcomes for different age groups and genders Still, this analysis lays essential groundwork for future research into neurometabolic protection via GLP-1 therapies. Originally celebrated as breakthrough treatments for obesity and diabetes, these medications may now be poised to take on an even broader role in preventing neurodegenerative diseases. As Dr. Reddin concluded, 'This research marks a significant advancement in how we understand the brain benefits of diabetes medications.' This article is based on findings from a study published in JAMA Neurology (July 2024). While the research links GLP-1 drugs like Ozempic and Mounjaro to reduce dementia risk, it is observational and does not prove direct causation. Further studies are needed. Always consult a healthcare provider before making medication decisions. Also Read | 5 coffee routine habits that could be doing more harm than good, say experts